1. Home
  2. author

author

Fear & Greed Index In ‘Greed’ Zone; S&P 500 Hits Record High After April Inflation Report

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the “Greed” zone on Wednesday. U.S. stocks settled higher on Wednesday, with the S&P 500 surging to a record high level during the session. On the economic data front, U.S. consumer prices rose 0.3% month-over-month in […]

Lifeway Foods Q1 Earnings Miss, Sales Beat Estimates

Lifeway Foods, Inc. (NASDAQ: LWAY) posted first-quarter 2024 results, wherein the top line beat the Zacks Consensus Estimate, while the bottom line missed the same. Both net sales and earnings experienced a year-over-year increase. Amid macro headwinds, LWAY has notably achieved a significant boost in net sales, particularly driven by strategic sales and marketing investments. […]

Bitfarms Ltd. Reports Q1 Loss, Lags Revenue Estimates

Bitfarms Ltd. (NASDAQ: BITF) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it […]

Contact Lens Maker Alcon’s Has New Growth Avenues, Analyst Upgrades Stock

Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced acquisition of BELKIN Vision for $60 million immediately and up to $335 million with milestone payments. Via the BELKIN Vision deal, Alcon adds FDA-approved Eagle direct-SLT for glaucoma. Selective Laser Trabeculoplasty (SLT) stimulates the trabecular […]

Wall Street Jumps To All-Time Highs On Soft Inflation, Bond Yields Tumble, Bitcoin Soars, Meme Stocks Face Carnage: What’s Driving Markets Wednesday?

The S&P 500 and the Nasdaq 100 indices rose to fresh record highs during morning trading on Wednesday following a broadly in-line inflation report and cooler-than-expected retail sales data for April, as traders increased their rate cut bets. Inflation calculated on the Consumer Price Index (CPI) basket came in at 3.4% year-on-year in April 2024, […]

Will Home Depot Continue To Weather Macro Challenges? ‘Continued Softness In Discretionary Projects,’ But ‘Compelling Recovery Opportunity’ Say Analysts

Home Depot Inc (NYSE:HD) shares were climbing in early trading on Wednesday, despite the company reporting disappointing first-quarter sales. The results came amid an exciting earnings season. Here are some key analyst takeaways. Truist Securities On Home Depot Analyst Scot Ciccarelli reiterated a Buy rating while cutting the price target from $417 to $406. Home […]

DHT Holdings Q1 Earnings and Revenues Lag Estimates

DHT Holdings (NYSE: DHT) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -6.45%. A quarter ago, it was expected […]

The Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue Estimates

The Oncology Institute, Inc. (NASDAQ: TOI) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -83.33%. A quarter […]

Alibaba Analysts Look For Signs Of Q4 Rebound: ‘Cloud Business Could Record Double-Digit Growth In 2025’

Shares of Alibaba Group Holding Ltd (NYSE:BABA) remained volatile in early trading on Wednesday, after the company reported results for its fiscal fourth quarter. The results came amid an exciting earnings season. Here are some key analyst takeaways. Mizuho Securities analyst James Lee maintained a Buy rating, while reducing the price target from $95 to […]

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Deutsche Bank analyst Bryan Keane downgraded the rating on Accenture plc (NYSE:ACN) from Buy to Hold, while slashing the price target from $409 to $295. […]